Analysis of survival and prognostic factors in treatment of hepatocellular carcinoma in Spanish patients with drug-eluting bead transarterial chemoembolization

Sanchez-Delgado Jordi; Vergara Mercedes; Machlab Salvador; Lira Alba; Gomez Zaragoza Carlos; Criado Eva; Rosinach Merce; Batista Lissette; Arau Beatriz; Roget Merce; Ortiz Jordi; Garcia Caridad; Sort Pau; Casas Meritxell; Dalmau Blai; Forne Montserrat; Falco Joan; Miquel Mireia

首页> 外文期刊>European journal of gastroenterology and hepatology >Analysis of survival and prognostic factors in treatment of hepatocellular carcinoma in Spanish patients with drug-eluting bead transarterial chemoembolization

【24h】

Analysis of survival and prognostic factors in treatment of hepatocellular carcinoma in Spanish patients with drug-eluting bead transarterial chemoembolization

机译：用于治疗西班牙乳胶龙霉化疗栓塞西班牙患者肝细胞癌的存活和预后因素分析

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background and aim Drug-eluting bead transarterial chemoembolization (DEB-TACE) improves the survival of patients with hepatocellular carcinoma (HCC), intermediate stage [i.e. Barcelona Clinic Liver Cancer-B (BCLC-B)]. The aim of our study was to analyse the overall survival (OS) and prognostic factors of patients with HCC treated with DEB-TACE.

机译：背景和目标药物洗脱珠霉咀栓塞（DEB-TACE）改善了肝细胞癌（HCC），中间阶段的患者的存活率[即巴塞罗那临床肝癌-B（BCLC-B）]。我们的研究目的是分析用DEB-TACE治疗HCC患者的整体存活（OS）和预后因素。

著录项

来源
《European journal of gastroenterology and hepatology 》 |2018年第12期| 共8页
作者
Sanchez-Delgado Jordi; Vergara Mercedes; Machlab Salvador; Lira Alba; Gomez Zaragoza Carlos; Criado Eva; Rosinach Merce; Batista Lissette; Arau Beatriz; Roget Merce; Ortiz Jordi; Garcia Caridad; Sort Pau; Casas Meritxell; Dalmau Blai; Forne Montserrat; Falco Joan; Miquel Mireia;
展开▼
作者单位

Univ Autonoma Barcelona Hepatol Unit Dept Gastroenterol I3PT Parc Tauli Hosp Univ Sabadell;

Univ Autonoma Barcelona Hepatol Unit Dept Gastroenterol I3PT Parc Tauli Hosp Univ Sabadell;

Univ Autonoma Barcelona Hepatol Unit Dept Gastroenterol I3PT Parc Tauli Hosp Univ Sabadell;

Univ Autonoma Barcelona Hepatol Unit Dept Gastroenterol I3PT Parc Tauli Hosp Univ Sabadell;

Univ Autonoma Barcelona Dept Radiol Parc Tauli Hosp Univ UDIAT Sabadell Spain;

Univ Autonoma Barcelona Dept Radiol Parc Tauli Hosp Univ UDIAT Sabadell Spain;

Univ Cent Barcelona Dept Gastroenterol Hosp Univ Mutua Terrassa Barcelona Spain;

Univ Cent Barcelona Dept Gastroenterol Hosp Univ Mutua Terrassa Barcelona Spain;

Univ Cent Barcelona Dept Gastroenterol Hosp Univ Mutua Terrassa Barcelona Spain;

Consorci Hosp Terrassa Hepatol Funct Unit Dept Gastroenterol Terrassa Spain;

Consorci Hosp Terrassa Hepatol Funct Unit Dept Gastroenterol Terrassa Spain;

Consorci Sanitari Terrassa Dept Radiol Terrassa Spain;

Althaia Xarxa Assistencial Univ Manresa Manresa Spain;

Univ Autonoma Barcelona Hepatol Unit Dept Gastroenterol I3PT Parc Tauli Hosp Univ Sabadell;

Univ Autonoma Barcelona Hepatol Unit Dept Gastroenterol I3PT Parc Tauli Hosp Univ Sabadell;

Inst Carlos III CIBEREHD Madrid Spain;

Inst Carlos III CIBEREHD Madrid Spain;

Univ Autonoma Barcelona Hepatol Unit Dept Gastroenterol I3PT Parc Tauli Hosp Univ Sabadell;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病 ;
关键词
drug-eluting beads; hepatocellular carcinoma; prognostic factors; survival analysis; transarterial chemoembolization;

机译：药物洗脱珠子;肝细胞癌;预后因素;存活分析;rantarterial Chemoembolization;

相似文献

外文文献
中文文献
专利

1. Analysis of survival and prognostic factors in treatment of hepatocellular carcinoma in Spanish patients with drug-eluting bead transarterial chemoembolization [J] . Sanchez-Delgado Jordi, Vergara Mercedes, Machlab Salvador, European journal of gastroenterology and hepatology . 2018 ,第12期

机译：用于治疗西班牙乳胶龙霉化疗栓塞西班牙患者肝细胞癌的存活和预后因素分析
2. 4:03 PM Abstract No. 378 Sorafenib combined with drug-eluting bead transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma with intrahepatic vascular shunts: the imaging prognostic factors related to patient survival [J] . M. Tsai, Y. Shih, P. Chang, Journal of vascular and interventional radiology: JVIR . 2018 ,第4Suppla期

机译：下午4:03摘要378号索拉非尼结合药物洗脱珠霉咀化疗，用于治疗肝内血管分流的先进肝细胞癌：与患者存活相关的成像预后因素
3. Retrospective analysis of efficacy, safety, and prognostic factors in a cohort of Chinese hepatocellular carcinoma patients treated with drug-eluting bead transarterial chemoembolization [J] . Chen Sihan, Ji Rengbin, Shi Xiaojun, Brazilian Journal of Medical and Biological Research . 2019 ,第12期

机译：用药物洗脱珠霉变化疗栓塞治疗中国肝细胞癌患者的疗效，安全性和预后因素的回顾性分析
4. Evaluation of hepatocellular carcinoma transarterial chemoembolization using 3D contrast enhanced ultrasound time-intensity curve analysis [C] . Kibo Nam, Maria Stanczak, Flemming Forsberg, IEEE International Ultrasonics Symposium . 2017

机译：使用3D对比增强超声时间强度曲线分析评估肝细胞癌经动脉化疗栓塞
5. Analysis of prognostic factors for the development of metastases and survival in renal cell carcinoma patients [D] . Cheng, Jed-Sian 2008

机译：肾细胞癌患者转移和存活的预后因素分析
6. Retrospective analysis of efficacy safety and prognostic factors in a cohort of Chinese hepatocellular carcinoma patients treated with drug-eluting bead transarterial chemoembolization [O] . Sihan Chen, Rengbin Ji, Xiaojun Shi, 2019

机译：回顾性分析药物洗脱小珠经动脉化疗栓塞治疗的中国肝细胞癌患者的疗效安全性和预后因素
7. Abstract No. 518 Comprehensive analysis of treatment response and survival profiles in hepatocellular carcinoma patients: drug-eluting beads transarterial chemoembolization with CalliSpheres microspheres versus conventional transarterial chemoembolization [O] . C. Zheng, H. Xiang, C. Ma 2019

机译：摘要肝细胞癌患者治疗响应和存活谱的综合分析：药物洗脱珠子曲调与愈合球菌微球的曲调化疗与常规曲调化疗栓塞

Analysis of survival and prognostic factors in treatment of hepatocellular carcinoma in Spanish patients with drug-eluting bead transarterial chemoembolization

摘要

著录项

相似文献

相关主题

期刊订阅